MDS Treatment Takes a Team
There are multiple key players, including oncology nurses, in the treatment of patients with myelodysplastic syndrome.
It takes a team to treat patients with myelodysplastic syndrome (MDS), explained Nancy Corbitt, BSN, RN, OCN, CRNI, survivorship nurse navigator at the University of Maryland Greenbaum Cancer Center and member of the AAMDS International Foundation.
At the ONS Annual Congress, Corbitt discussed some of the key players in caring for those with MDS. They include the physician, who will discuss diagnosis and treatments, the oncology nurses who often focus on adverse event management, as well as palliative and advanced care planning specialists.
UGN-102 Produces Comparable Responses Regardless of Surgery in NMIBC Subset
May 8th 2024Patients with newly diagnosed and recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer treated with UGN-102 displayed meaningful and similar responses and disease-free survival regardless of whether they underwent surgery.
Verification Nurse Provides ‘Significant Contribution to Patient Safety’ During Chemo Administration
May 1st 2024The role of a verification nurse can lead to several benefits, including the prevention of errors from reaching the patient, decreased workload, and potential cost savings from less drug waste.
